Latest Orphan drugs Stories
CAMBRIDGE, Mass., May 14, 2015 /PRNewswire/ -- Boston Biomedical, an industry leader in the development of novel compounds
86% Response Rate Observed at Highest Dose of GEN-1 in Platinum Resistant Ovarian Cancer LAWRENCEVILLE, N.J., May 13, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a fully
Abstracts: 5034, TPS5082, 5063, TPS1104, 3558, 3560, 6015, TPS5080 WHIPPANY, N.J., May 13, 2015 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
THOUSAND OAKS, Calif., May 13, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data at the 51(st) Annual Meeting of the American Society of Clinical Oncology (ASCO) will showcase the
17 abstracts include data from: NORTH CHICAGO, Ill., May 11, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from studies of the company's oncology pipeline are being presented
SUNNYVALE, Calif., May 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
RnRMarketResearch.com adds “Metastatic Ovarian Cancer – Pipeline Review, H1 2015” to its store.
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
RnRMarketResearch.com adds "Pulmonary Hypertension - Pipeline Review, H1 2015" to its store.
SARATOGA, Calif., March 18, 2015 /PRNewswire/ -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused
- A woman chauffeur.
- A woman who operates an automobile.